Postoperative complications and hospital costs following open radical cystectomy: A retrospective study.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2023
Historique:
received: 06 02 2023
accepted: 10 02 2023
entrez: 24 2 2023
pubmed: 25 2 2023
medline: 3 3 2023
Statut: epublish

Résumé

To evaluate primarily the relationship between postoperative complications and hospital costs, and secondarily the relationship between postoperative complications and mortality, following radical cystectomy. Postoperative complications were retrospectively examined for 147 patients undergoing radical cystectomy at a university hospital between January 2012 and July 2021. Complications were defined and graded using the Clavien-Dindo classification system. In-hospital cost was calculated using an activity-based costing methodology. Regression modelling was used to investigate the relationships among a priori selected perioperative variables, complications, and costs. The effect of complications on postoperative mortality was ascertained using time-dependent coefficients in a Cox proportional hazards regression model. 135 (92%) patients experienced one or more postoperative complications. The medians of hospital cost for patients who experienced no complications and those who experienced complications were $42,796.3 (29,222.9-53,532.5) and $81,050.1 (49,614.8-122,533.6) respectively, p < 0.001. Hospital costs were strongly associated with complication severity: Clavien-Dindo grade II complications increased costs by 45.2% (p < 0.001, 95% CI 19.1%-76.6%), and Clavien-Dindo grade III to V complications increased costs by 107.5% (p < 0.001, 95% CI 52.4%-181.8%). Each additional count of complication and increase in Clavien-Dindo complication grade increased the risk of mortality 1.28-fold (RR = 1.28, p = 0.006, 95% CI 1.08-1.53) and 2.50-fold (RR = 2.50, p = 0.012 95% CI 1.23-5.07) respectively. These findings demonstrate a high prevalence of complications following cystectomy and significant associated increases in hospital costs and mortality. Postoperative complications are a key target for cost-containment strategies. Trial Registration: Australian New Zealand Clinical Trials Registry (ACTRN:12622000057785.

Identifiants

pubmed: 36827411
doi: 10.1371/journal.pone.0282324
pii: PONE-D-23-03274
pmc: PMC9956632
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0282324

Informations de copyright

Copyright: © 2023 Weinberg et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

PLoS One. 2015 Mar 31;10(3):e0121032
pubmed: 25825873
Eur Urol. 2020 Dec;78(6):893-906
pubmed: 32972792
BJU Int. 2012 Oct;110(8):1163-8
pubmed: 22443271
Eur Urol. 2009 Jan;55(1):164-74
pubmed: 18675501
J Natl Compr Canc Netw. 2020 Mar;18(3):329-354
pubmed: 32135513
Cancer. 2010 Jan 15;116(2):331-9
pubmed: 19924831
CA Cancer J Clin. 2021 Jan;71(1):7-33
pubmed: 33433946
Eur Urol. 2018 Mar;73(3):374-382
pubmed: 28803034
Curr Med Res Opin. 2020 Jul;36(7):1177-1185
pubmed: 32314606
BJU Int. 2018 Mar;121(3):428-436
pubmed: 29063725
World J Urol. 2020 Dec;38(12):3155-3160
pubmed: 32124017
Eur Urol. 2016 Jul;70(1):195-202
pubmed: 27133087
J Surg Oncol. 2016 Feb;113(2):223-8
pubmed: 26696270
Cancer Epidemiol. 2013 Jun;37(3):219-25
pubmed: 23485480
J Urol. 2012 Jun;187(6):2011-7
pubmed: 22498229
Int J Cancer. 2021 Apr 5;:
pubmed: 33818764
Eur J Anaesthesiol. 2015 Feb;32(2):88-105
pubmed: 25058504
J Chronic Dis. 1987;40(5):373-83
pubmed: 3558716
Int J Surg. 2017 Oct;46:198-202
pubmed: 28890409
Ann Surg. 2004 Aug;240(2):205-13
pubmed: 15273542
Clin Genitourin Cancer. 2019 Jun;17(3):e488-e493
pubmed: 30837209
Transl Androl Urol. 2020 Aug;9(4):1743-1753
pubmed: 32944535
Urol Oncol. 2017 Nov;35(11):659.e13-659.e19
pubmed: 28778584
Cancer. 2014 May 1;120(9):1409-16
pubmed: 24477968
BJU Int. 2019 Oct;124(4):656-664
pubmed: 31055865

Auteurs

Laurence Weinberg (L)

Department of Anesthesia, Austin Health, Heidelberg, Australia.
Department of Surgery, The University of Melbourne, Austin Health, Heidelberg, Australia.
Department of Critical Care, The University of Melbourne, Austin Health, Heidelberg, Australia.

Sarah Aishah Azlina Aitken (SAA)

Department of Anesthesia, Austin Health, Heidelberg, Australia.

Peter Kaldas (P)

Department of Surgery, The University of Melbourne, Austin Health, Heidelberg, Australia.

Luke Fletcher (L)

Department of Surgery, The University of Melbourne, Austin Health, Heidelberg, Australia.
Data Analytics Research and Evaluation (DARE) Centre, Austin Health, Heidelberg, Australia.

Patryck Lloyd-Donald (P)

Department of Anesthesia, Austin Health, Heidelberg, Australia.

Peter Le (P)

Department of Anesthesia, Austin Health, Heidelberg, Australia.

Daniel Do (D)

Department of Anesthesia, Austin Health, Heidelberg, Australia.

Carla Borg Caruana (CB)

Department of Anesthesia, Austin Health, Heidelberg, Australia.

Dominic Walpole (D)

Department of Anesthesia, Austin Health, Heidelberg, Australia.

Joseph Ischia (J)

Department of Surgery, The University of Melbourne, Austin Health, Heidelberg, Australia.

Ronald Ma (R)

Business Intelligence Unit, Austin Health, Heidelberg, Australia.

Chong Oon Tan (CO)

Department of Anesthesia, Austin Health, Heidelberg, Australia.

Dong-Kyu Lee (DK)

Department of Anesthesiology and Pain Medicine, Dongguk University Ilsan Hospital, Goyang, Republic of Korea.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH